ALABAstera Labs, Inc.
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Price is +48% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Moderately shorted, settled Sep 15, 2026, a few days of normal trading to cover. Down 3.9% since the previous count, down from 6.4% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ALAB is trading
Astera Labs, Inc. is +40% over the past year while the S&P 500 is +18%: 21 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +48%
vs 200-day average · a clear uptrend
- RSI (14)
- 51
RSI (14) · neutral
- Below its 52-week high
- 22%
Below its 52-week high
Details›
- Last close2026-10-09
- $342.14
- 1 monthS&P 500 +2.7%
- +20%
- 1 yearS&P 500 +18%
- +40%
- vs 50-day average$316.01
- +8.3%
- 52-week high
- $439.66
- 52-week low
- $100.27
- Annualised volatility
- 95%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$110M
| Year | Return |
|---|---|
| 2026 (year to date) | +106% |
| 2025 | +26% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 2 | 0 of 2 | −16% |
| Feb | 2 | 0 of 2 | −24% |
| Mar | 2 | 0 of 2 | −14% |
| Apr | 3 | 3 of 3 | +34% |
| May | 3 | 2 of 3 | +30% |
| Jun | 3 | 1 of 3 | +3.2% |
| Jul | 3 | 1 of 3 | −3.9% |
| Aug | 3 | 2 of 3 | +16% |
| Sep | 3 | 3 of 3 | +16% |
| Oct | 3 | 1 of 3 | +8.5% |
| Nov | 2 | 1 of 2 | +16% |
| Dec | 2 | 2 of 2 | +17% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.